Suchergebnisse - "Curigliano, G"

PubPharm (286)

31

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment

enthalten in: European heart journal. Quality of care & clinical outcomes | 2022

von Lee, G. | Aktaa, S. | Baker, E. | +24

32

ESMO Expert Consensus Statements on Cancer Survivorship : promoting high-quality survivorship care and research in Europe

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Vaz-Luis, I. | Masiero, M. | Cavaletti, G. | +25

33

ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Paluch-Shimon, S. | Cardoso, F. | Partridge, A. | +20

34

Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy : update from the ARROW trial

enthalten in: Annals of oncology | 13 August 2022

von Griesinger, F. | Curigliano, G. | Thomas, M. | +23

35

Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy : update from the ARROW trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Griesinger, F. | Curigliano, G. | Thomas, M. | +23

CommentIn: Nat Rev Clin Oncol. 2022 Oct;19(10):615. - PMID 35999290

36

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

enthalten in: ESMO open | 2022

von Kanesvaran, R. | Castro, E. | Wong, A. | +21

37

Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Tarantino, P. | Jin, Q. | Mittendorf, E. | +3

38

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer : a report from the ESMO Precision Medicine Working Group

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Pascual, J. | Attard, G. | Bidard, F. | +17

39

Risk-adapted modulation through de-intensification of cancer treatments : an ESMO classification

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Trapani, D. | Franzoi, M. | Burstein, H. | +14

CommentIn: Ann Oncol. 2022 Jul;33(7):672-673. - PMID 35568278

40

Quantifying geographical accessibility to cancer clinical trials in different income landscapes

enthalten in: ESMO open | 2022

von Tini, G. | Trapani, D. | Duso, B. | +4